Upcoming Conferences and Earnings, Monthly Sales Numbers, and Technical Updates - Research Reports on Weyerhaeuser, Rite Aid, FedEx, Dollar Tree and GT

NEW YORK, September 10, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Weyerhaeuser Co. (NYSE: WY), Rite Aid Corporation (NYSE: RAD), FedEx Corporation (NYSE: FDX), Dollar Tree, Inc. (NASDAQ: DLTR) and GT Advanced Technologies Inc. (NASDAQ: GTAT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6347-100free.

--
Weyerhaeuser Co. Research Reports
On August 27, 2014, Weyerhaeuser Co. (Weyerhaeuser) - one of the world's largest private owners of timberlands - reported that Doyle Simons, President and CEO, will represent the Company at the UBS Conference in New York City, on September 11, 2014. Simons is scheduled to present at 1:45 p.m. ET. The full research reports on Weyerhaeuser are available to download free of charge at:

http://www.analystsreview.com/Sep-10-2014/WY/report.pdf

--
Rite Aid Corporation Research Reports
On September 5, 2014, Rite Aid Corporation (Rite Aid) said that it will publish its financial results for Q2 FY 2015 (period ended August 30, 2014), on September 18, 2014. The Company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. In a separate press release, a day before, Rite Aid reported that for the five weeks ended August 30, 2014, same store sales increased 3.9% YoY, while August front-end same store sales increased 1.1% YoY. Pharmacy same store sales, which included an approximate 219 basis points negative impact from new generic introductions, increased 5.2% YoY. Total drugstore sales for the above-mentioned period increased 3.7% YoY to c. $2.5 billion. Prescription sales accounted for 69.3% of drugstore sales, and third party prescription sales represented 97.5% of pharmacy sales. The full research reports on Rite Aid are available to download free of charge at:

http://www.analystsreview.com/Sep-10-2014/RAD/report.pdf

--
FedEx Corporation Research Reports
On September 5, 2014, shares in FedEx Corporation (FedEx) rose for the fifth consecutive trading session and closed at $153.30, up 0.83% from its previous day's close. The stock opened at $151.55 and fluctuated between $153.35 and $150.10. The stock is currently trading near its 52-week high of $155.31. The stock has a year-till-date return of 9.68%, outperforming its competitor - United Parcel Services, which declined 5.92% during the same time period. The full research reports on FedEx are available to download free of charge at:

http://www.analystsreview.com/Sep-10-2014/FDX/report.pdf

--
Dollar Tree, Inc. Research Reports
On September 5, 2014, Dollar Tree, Inc. (Dollar Tree) and Family Dollar Stores, Inc. (Family Dollar) announced that the two companies have modified their merger agreement to include a commitment by Dollar Tree to divest as many stores as needed or advisable to obtain antitrust clearance for the previously announced cash and stock transaction. The Companies confirmed that all other terms and conditions of the merger agreement remain the same as announced on July 28, 2014. Under the terms of the agreement, Family Dollar shareholders will receive $59.60 in cash and $14.90 equivalent in Dollar Tree shares for each common share of Family Dollar owned, subject to a collar. Further, the two companies also announced that they now expect the transaction to close as early as by the end of November 2014, as against early 2015 that was anticipated earlier. The full research reports on Dollar Tree are available to download free of charge at:

http://www.analystsreview.com/Sep-10-2014/DLTR/report.pdf

--
GT Advanced Technologies Inc. Research Reports
As per an SEC filing reported by GT Advanced Technologies (GT), dated September 4, 2014, the Company's Chief Operating Officer Daniel Squiller sold 15,000 GT shares on September 2, 2014 at a price of $18.00. Post the transaction, Squiller holds 232,735 shares in the Company. The full research reports on GT are available to download free of charge at:

http://www.analystsreview.com/Sep-10-2014/GTAT/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review